← Back to Clinical Trials
Recruiting NCT07552909

NCT07552909 A Random Controlled Trial of Home-based Digital Therapy for Treating ADHD in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07552909
Status Recruiting
Phase
Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Condition Attention Deficit Hyperactivity Disorder (ADHD)
Study Type INTERVENTIONAL
Enrollment 146 participants
Start Date 2025-08-24
Primary Completion 2026-05-31

Trial Parameters

Condition Attention Deficit Hyperactivity Disorder (ADHD)
Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Study Type INTERVENTIONAL
Phase N/A
Enrollment 146
Sex ALL
Min Age 7 Years
Max Age 11 Years
Start Date 2025-08-24
Completion 2026-05-31
Interventions
Home-based digital therapy with brain-controlled games

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Explore the interventional effects of neurofeedback games on school-aged children with mild to moderate ADHD, with the aim of providing evidence-based new methods for intervening in the core symptoms of ADHD in children.

Eligibility Criteria

Inclusion Criteria: * Children aged 7 years 0 months to 11 years 11 months * Clinical diagnosis of ADHD made by a child psychiatrist at the attending level or above * Wechsler Intelligence Scale for Children (WISC) Full Scale IQ (FSIQ) above 85 * Children who have been diagnosed with ADHD but have not received any intervention (newly diagnosed within the last month or not having taken medication for at least 4 weeks) * Informed consent must be obtained from the patient/guardian and from participants Exclusion Criteria: * Auditory or visual illness or disorder * Inability to use software (e.g., color blindness, impaired hand function, or disability) * Comorbid oppositional defiant disorder, autism spectrum disorder, pervasive developmental disorder, tic disorders, or other neurodevelopmental disorders * Other mental illnesses such as organic mental disorders, schizophrenia, bipolar disorder, or depressive disorders * Attention deficit disorder caused by organic neurological diseases or

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology